These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Bronchial carcinoid studied by spiral computed tomography with 3-dimensional reconstructions and virtual endoscopy. A case]. Aliberti C; Benetti S; Benea G Radiol Med; 2000; 100(1-2):71-3. PubMed ID: 11109458 [No Abstract] [Full Text] [Related]
43. Internalization of indium-111 into human neuroendocrine tumor cells after incubation with indium-111-DTPA-D-Phe1-octreotide. Andersson P; Forssell-Aronsson E; Johanson V; Wängberg B; Nilsson O; Fjälling M; Ahlman H J Nucl Med; 1996 Dec; 37(12):2002-6. PubMed ID: 8970523 [TBL] [Abstract][Full Text] [Related]
44. Use of somatostatin analog for localization and treatment of ACTH secreting bronchial carcinoid tumor. Christin-Maitre S; Chabbert-Buffet N; Mure A; Boukhris R; Bouchard P Chest; 1996 Mar; 109(3):845-6. PubMed ID: 8617102 [TBL] [Abstract][Full Text] [Related]
45. [Somatostatin receptor scintigraphy. A new imaging procedure for the specific demonstration of carcinoids of the small intestine]. Dörr U; Räth U; Schürmann G; Höring E; Bach D; Wurm K; Scholz M; Adrian HJ; Bihl H Rofo; 1993 Jan; 158(1):67-73. PubMed ID: 8425079 [TBL] [Abstract][Full Text] [Related]
46. Value of peptide receptor scintigraphy using (123)I-vasoactive intestinal peptide and (111)In-DTPA-D-Phe1-octreotide in 194 carcinoid patients: Vienna University Experience, 1993 to 1998. Raderer M; Kurtaran A; Leimer M; Angelberger P; Niederle B; Vierhapper H; Vorbeck F; Hejna MH; Scheithauer W; Pidlich J; Virgolini I J Clin Oncol; 2000 Mar; 18(6):1331-6. PubMed ID: 10715305 [TBL] [Abstract][Full Text] [Related]
47. Hilar bronchial carcinoid tumor: increased peritumoral vascular expression of somatostatin-2 receptor on an octreotide study? Koh E; Patrikeos A; Steens R; Robins P Clin Nucl Med; 2001 Oct; 26(10):870-1. PubMed ID: 11564931 [No Abstract] [Full Text] [Related]
48. Carcinoid tumours presenting as breast cancer: the utility of radionuclide imaging with 123I-MIBG and 111In-DTPA pentetreotide. Kaltsas GA; Putignano P; Mukherjee JJ; Satta MA; Lowe DG; Britton KE; Monson JP; Grossman AB; Besser GM Clin Endocrinol (Oxf); 1998 Nov; 49(5):685-9. PubMed ID: 10197087 [TBL] [Abstract][Full Text] [Related]
49. Primary ovarian trabecular carcinoid tumour: a case report with an immunohistochemical study and a review of the literature. De la Torre J; García A; Castellví J; López M; Gil A Arch Gynecol Obstet; 2004 Dec; 270(4):274-7. PubMed ID: 12774237 [TBL] [Abstract][Full Text] [Related]
51. 131I MIBG/111In octreotide mismatch in a patient with liver metastases secondary to a carcinoid of unknown origin. Orsolon P; Bagni B Minerva Endocrinol; 1995 Jun; 20(2):145-7. PubMed ID: 8531897 [TBL] [Abstract][Full Text] [Related]
52. Metastatic carcinoid tumor imaged with CT and a radiolabeled somatostatin analog: a case report. Lobrano MB; McCarthy K; Adams L; Neitzschman H Am J Gastroenterol; 1997 Mar; 92(3):513-5. PubMed ID: 9068482 [TBL] [Abstract][Full Text] [Related]